翔宇医疗：超六成研发投向脑机接口领域，明年合作医院将覆盖至1000家

Core Insights - Brain-computer interface (BCI) technology has achieved a significant breakthrough in policy, with Shanghai Ladder Medical Technology Co., Ltd. announcing that its "implantable wireless brain-computer interface system" has entered the special review process for innovative medical devices by the National Medical Products Administration, marking a transition from laboratory to clinical application [1] - Interest in companies related to brain-computer interfaces has surged, with over ten brokerages and several investment funds conducting joint research on Xiangyu Medical [1] Company Developments - Xiangyu Medical reported a total R&D investment of 49.0947 million yuan in the third quarter, representing a year-on-year increase of 27.67%, with approximately 60%-70% allocated to brain-computer interface-related fields [2] - The company has established strategic partnerships with over 260 large hospitals to develop brain-computer interface treatment centers and research-oriented wards, aiming to cover 500 top-tier hospitals by the Spring Festival and expand to over 1,000 hospitals next year, with progress ahead of expectations [2] - Xiangyu Medical's innovative products, including those utilizing brain-computer interface technology, present new opportunities for collaboration with high-level hospitals, enhancing the company's brand positioning and influence in the high-end hospital market [2]